$1.13
-0.06-5.04%
At Close: -
$1.15
0.021.77%
After Hours: 4:29 PM EDT
15 minutes delayed
Comments
Loading...
CARISMA Therapeutics (NASDAQ:CARM) Stock, Earnings Estimates, EPS, And Revenue
CARISMA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS Estimate
$-0.280
Quarterly Revenue Estimate
$5M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$20.7M
Analyze the earnings history of CARISMA Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
CARISMA Therapeutics (CARM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.27 | $-0.30 | 10.0 % |
| Mar 2024 | 2024-05-09 | $-0.46 | $-0.43 | -6.98 % |
| Mar 2024 | 2024-04-01 | $-0.52 | $-0.55 | 5.45 % |
| Sep 2023 | 2023-11-09 | $-0.53 | $-0.57 | 7.02 % |
CARISMA Therapeutics (CARM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $9.20M | $3.92M | 134.6 % |
| Mar 2024 | 2024-05-09 | $3.40M | $4.40M | -22.8 % |
| Mar 2024 | 2024-04-01 | $4.29M | $2.90M | 47.9 % |
| Sep 2023 | 2023-11-09 | $3.83M | $1.20M | 218.9 % |
FAQ
When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?
CARISMA Therapeutics (CARM) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for CARISMA Therapeutics (NASDAQ:CARM)?
The Actual EPS was $-0.27, which beat the estimate of $-0.30.
What were CARISMA Therapeutics’s (NASDAQ:CARM) revenues?
The Actual Revenue was $9.2M, which beat the estimate of $3.9M.
Browse earnings estimates, EPS, and revenue on all stocks.